Growth Metrics

MeiraGTx Holdings (MGTX) Net Margin (2019 - 2025)

MeiraGTx Holdings posted quarterly Net Margin of 20.02% for Q4 2025, up 20421.0% year-on-year from N/an in Q4 2024, and up 100.16% on a QoQ basis from 12320.24% in Q3 2025.

MeiraGTx Holdings (MGTX) has 7 years of Net Margin data on file, last reported at 20.02% in Q4 2025.

  • For the quarter ending Q4 2025, Net Margin rose 20421.0% year-over-year to 20.02%; the trailing twelve-month figure through Dec 2025 stood at 113.23% (up 33086.0% YoY), and the FY2025 full-year result was 140.31%, up 30379.0% from the prior year.
  • Net Margin for Q4 2025 stood at 20.02%, up from 12320.24% in the prior quarter.
  • Across five years, Net Margin topped out at 990.93% in Q4 2023 and bottomed at 17241.13% in Q2 2024.
  • The 5-year median for Net Margin is 513.97% (2021), against an average of 2007.64%.
  • The widest annual swing landed in 2024, when Net Margin slumped 1640551 bps; it then surged 1619006 bps in 2025.
  • A 5-year view of Net Margin shows it stood at 47.1% in 2021, then soared by 1197 bps to 516.51% in 2022, then soared by 92 bps to 990.93% in 2023, then plunged by 119 bps to 184.19% in 2024, then soared by 111 bps to 20.02% in 2025.
  • The last three Net Margin figures came in at 20.02% (Q4 2025), 12320.24% (Q3 2025), and 1051.07% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 34.53%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 17.65%
10 MeiraGTx Holdings 856.58 Mn 790.65 Mn 74.89 Mn 20.02%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 20.02%
Sep 30, 2025 -12,320.24%
Jun 30, 2025 -1,051.07%
Dec 31, 2024 -184.19%
Sep 30, 2024 -360.49%
Jun 30, 2024 -17,241.13%
Mar 31, 2024 -2,932.86%
Dec 31, 2023 990.93%
Sep 30, 2023 -868.06%
Jun 30, 2023 -835.62%
Mar 31, 2023 -910.74%
Dec 31, 2022 516.51%
Sep 30, 2022 -774.17%
Jun 30, 2022 -315.76%
Mar 31, 2022 -551.13%
Dec 31, 2021 -47.10%
Sep 30, 2021 -373.42%
Jun 30, 2021 -392.61%
Mar 31, 2021 -513.97%
Dec 31, 2020 -276.16%
Sep 30, 2020 -126.32%
Jun 30, 2020 -1,027.41%
Mar 31, 2020 -372.47%
Dec 31, 2019 -78.95%
Sep 30, 2019 -291.99%
Jun 30, 2019 -1,050.75%
Mar 31, 2019 -2,290.81%